Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,513,008 | 1,497,775 | 1,326,730 | 1,043,241 | 1,832,684 |
Marketable Securities | 288,369 | 237,025 | 262,756 | 259,351 | 284,870 |
Receivables | 481,994 | 356,182 | 420,250 | 351,522 | 308,809 |
Inventories | 16,425 | 17,012 | 16,335 | 13,977 | 11,400 |
TOTAL | $2,359,894 | $2,159,425 | $2,077,625 | $1,716,169 | $2,481,488 |
Non-Current Assets | |||||
PPE Net | 559,625 | 498,335 | 453,777 | 410,034 | 377,567 |
Investments And Advances | 222,301 | 225,473 | 248,731 | 180,993 | 133,657 |
Intangibles | 172,291 | 333,268 | 183,060 | 344,037 | 193,828 |
Other Non-Current Assets | 246,807 | 90,929 | 249,128 | 101,189 | 240,210 |
TOTAL | $1,201,024 | $1,148,005 | $1,134,696 | $1,036,253 | $945,262 |
Total Assets | $3,560,918 | $3,307,430 | $3,212,321 | $2,752,422 | $3,426,750 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 11,900 | 18,588 | 18,524 | 18,300 |
Accounts payable and accrued liabilities | 98,767 | 122,568 | 90,938 | 61,026 | 83,647 |
Accrued Expenses | 530,144 | 469,756 | 445,798 | 422,952 | 410,729 |
TOTAL | $631,195 | $606,202 | $556,513 | $503,412 | $513,340 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | 285,882 | 277,547 | 279,287 | 279,330 | 283,086 |
TOTAL | $318,455 | $310,395 | $311,204 | $311,289 | $315,004 |
Total Liabilities | $949,650 | $916,597 | $867,717 | $814,701 | $828,344 |
Shareholders' Equity | |||||
Shares Outstanding, K | 219,844 | 218,996 | 218,699 | 217,374 | 216,776 |
Common Shares | 219 | 219 | 218 | 217 | 216 |
Retained earnings | -1,726,455 | -1,876,305 | -1,861,102 | -2,151,400 | -1,430,758 |
Other shareholders' equity | -15,360 | -9,748 | -12,423 | -13,107 | -15,542 |
TOTAL | $2,611,268 | $2,390,833 | $2,344,604 | $1,937,721 | $2,598,406 |
Total Liabilities And Equity | $3,560,918 | $3,307,430 | $3,212,321 | $2,752,422 | $3,426,750 |